Arkolith/Insider Trading/XFOR/Form 4

DiBiase Mary

Chief Operating OfficerX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Mar 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2024Sell(S)15K$0.88$14K292K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-010278) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML